Who owns Xpress Biologics?

Xpress Biologics is formerly owned by ARCHIMED, through MED III, since 2021.

When did ARCHIMED acquire Xpress Biologics?

ARCHIMED acquired Xpress Biologics in 2021 and exited after 1 year.

Has Xpress Biologics been sold?

Yes. Xpress Biologics was exited in 2022 via Trade Sale.

Home/Companies/Biotech/Xpress Biologics

Xpress Biologics

Biotech·

Belgium·Exited 2022·Held 1yr

Xpress Biologics is a life science tools & biologic services company, headquartered in Belgium.

Entry

2021

Hold

1yr

Exit

2022

Est. EV

–

Investor

ARCHIMED

Key facts

HQBelgium

SectorLife Science Tools & Biologic Services

Founded in 2014, headquartered in Belgium, Xpress Biologics is a Biologics Contract Development and Manufacturing Organization (CDMO)…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from MED III

Other portfolio companies in the same fund.

Title21 Health Solutions

Active

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings